SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001551163-16-000544
Filing Date
2016-11-21
Accepted
2016-11-21 12:38:36
Documents
26
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 f1v193016form10q_20161109ved.htm 10-Q 226144
2 exhibit3101.htm EX-31 8543
3 exhibit3102.htm EX-31 9104
4 exhibit3201.htm EX-32 4251
  Complete submission text file 0001551163-16-000544.txt   694847

Data Files

Seq Description Document Type Size
5 sgbi-20160930.xml EX-101.INS 35444
6 sgbi-20160930.xsd EX-101.SCH 7039
7 sgbi-20160930_cal.xml EX-101.CAL 14238
8 sgbi-20160930_def.xml EX-101.DEF 4884
9 sgbi-20160930_lab.xml EX-101.LAB 59938
10 sgbi-20160930_pre.xml EX-101.PRE 45285
Mailing Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025
Business Address 291 SOUTH 200 WEST P.O. BOX 832 FARMINGTON UT 84025 011 49 1607 412717
SANGUI BIOTECH INTERNATIONAL INC (Filer) CIK: 0001104280 (see all company filings)

IRS No.: 841330732 | State of Incorp.: CO | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-29233 | Film No.: 162009702
SIC: 2834 Pharmaceutical Preparations